---
figid: PMC6393772__fig-6
figtitle: 'Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the
  NADPH Oxidase NOX1–5 and Superoxide Dismutase 1–3 Signal Transduction Pathways'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6393772
filename: fig-6.jpg
figlink: /pmc/articles/PMC6393772/figure/f6/
number: F6
caption: SOD2 and SOD3 in cell metastasis and in cell survival. (A) SOD2 promotes
  metastatic signaling molecule activation and inhibits apoptosis by downregulating
  caspase 3 and TRAIL, and by upregulating EMT mediating proteins and MMPs. (B) RTK-SRC-RAS-ERK1/2,
  GPCR-cAMP-PKA, and GPCR-PLC-Ca2+signaling activate SOD3 production, thereby increasing
  cell proliferation and survival. Positive feedback signaling increases RTK phosphorylation
  and RAS GTP loading, thus maintaining activity of the RAS-ERK1/2 cascade. (C) RAS
  controls SOD3 expression through epigenetics, by p38MAPK activation, and by the
  PI3K-AKT-FOXO3a pathway. PI3K-AKT activation causes phosphorylation of the transcription
  factor, FOXO3a, resulting in its transfer from the nucleus to the cytoplasm, thereby
  increasing mir21 synthesis, which targets SOD3 mRNA. EMT, epithelial/mesenchymal
  transition; FOXO, forkhead box family; PI3K, phosphatidylinositol-4,5-bisphosphate
  3-kinase; TRAIL, TNF-related apoptosis-inducing ligand.
papertitle: 'Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of
  the NADPH Oxidase NOX1–5 and Superoxide Dismutase 1–3 Signal Transduction Pathways.'
reftext: Alessia Parascandolo, et al. Antioxid Redox Signal. 2019 Jan 20;30(3):443-486.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8466864
figid_alias: PMC6393772__F6
figtype: Figure
redirect_from: /figures/PMC6393772__F6
ndex: 81a11187-df22-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6393772__fig-6.html
  '@type': Dataset
  description: SOD2 and SOD3 in cell metastasis and in cell survival. (A) SOD2 promotes
    metastatic signaling molecule activation and inhibits apoptosis by downregulating
    caspase 3 and TRAIL, and by upregulating EMT mediating proteins and MMPs. (B)
    RTK-SRC-RAS-ERK1/2, GPCR-cAMP-PKA, and GPCR-PLC-Ca2+signaling activate SOD3 production,
    thereby increasing cell proliferation and survival. Positive feedback signaling
    increases RTK phosphorylation and RAS GTP loading, thus maintaining activity of
    the RAS-ERK1/2 cascade. (C) RAS controls SOD3 expression through epigenetics,
    by p38MAPK activation, and by the PI3K-AKT-FOXO3a pathway. PI3K-AKT activation
    causes phosphorylation of the transcription factor, FOXO3a, resulting in its transfer
    from the nucleus to the cytoplasm, thereby increasing mir21 synthesis, which targets
    SOD3 mRNA. EMT, epithelial/mesenchymal transition; FOXO, forkhead box family;
    PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; TRAIL, TNF-related apoptosis-inducing
    ligand.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sod2
  - Decay
  - sna
  - slug
  - Mmp1
  - tra2
  - CadN
  - Tie
  - Ras85D
  - InR
  - Oamb
  - Src42A
  - Csk
  - Src64B
  - gas
  - Galphas
  - gd
  - Galphaq
  - CG17760
  - CG30054
  - ras
  - Ras64B
  - norpA
  - sl
  - Plc21C
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - rl
  - Sod3
  - Nplp1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - foxo
  - Dsor1
  - MKP-4
  - p38b
  - p38a
  - p38c
  - lic
  - Nurf-38
  - Ebp
  - AIMP2
  - Hrb87F
  - SOD2
  - SOD2-OT1
  - ZEB2
  - ITK
  - SLC22A3
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - SNAI1
  - SNAI2
  - TNFSF10
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - CDH2
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - SRC
  - FGR
  - FYN
  - YES1
  - GAST
  - GALNS
  - PAGR1
  - GNAQ
  - KRAS
  - HRAS
  - NRAS
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - BRAF
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - MAPK3
  - MAPK1
  - SOD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MIR21
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - MAP2K1
  - MAP2K2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - GRAP2
  - AHSA1
  - POLDIP2
  - Ca2+
  - Cancer
  - Lung cancer
---
